Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Falco Holdings Co., Ltd. is a prominent Japanese healthcare group specializing in clinical laboratory testing and pharmaceutical services. The company's core operations are divided into clinical diagnostics, genomic medicine, and the management of dispensing pharmacies. Through its primary subsidiary, Falco Biosystems, the group provides advanced genetic testing and companion diagnostics that facilitate personalized cancer treatments and support clinical decision-making. Additionally, Falco Holdings offers contract research services and life science support to pharmaceutical companies, aiding in the drug development process and clinical trial management. By integrating diagnostic precision with retail pharmacy expertise, the company plays a vital role in the Japanese medical infrastructure and the transition toward precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Falco Holdings.